Intersect ENT, Inc. SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
Intersect ENT, Inc. had SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount of $487.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-09.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesBalance · last filed 2021-03-09
- 2020-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $487.00K.
- 2019-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $131.00K.
- 2018-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $80.00K.
- 2017-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $150.00K.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount |
|---|---|
| 2020-12-31 | $487.00K 10-K · filed 2021-03-09 |
| 2019-12-31 | $131.00K 10-K · filed 2021-03-09 |
| 2018-12-31 | $80.00K 10-K · filed 2021-03-09 |
| 2017-12-31 | $150.00K 10-K · filed 2021-03-09 |
| 2016-12-31 | $162.00K 10-K · filed 2020-02-27 |
| 2015-12-31 | $86.00K 10-K · filed 2019-02-28 |